AIDS and Behavior

, Volume 17, Issue 7, pp 2479–2489

High Uptake of HIV Testing in a Cohort of Male Injection Drug Users in Delhi, India: Prevalence and Correlates of HIV Infection

  • Avina Sarna
  • Waimar Tun
  • Vartika Sharma
  • Mary Sebastian
  • Ira Madan
  • Amita Yadav
  • Meredith Sheehy
  • Dean Lewis
  • Ibou Thior
Original Paper

Abstract

We report baseline findings from a longitudinal cohort study to examine HIV incidence, high-risk injection and sexual behaviors of 3,792 male injection drug users (IDUs) in Delhi. The majority (95.4 %) accepted HIV testing; HIV prevalence was 21.9 %. In multivariate analysis, belonging to states adjacent to Delhi (AOR: 1.23; 95 % CI: 1.07–1.52), earning INR 500–1,500 (AOR: 2.38; 95 % CI: 1.43–3.96); duration of drug use 2–5 years (AOR: 2.02; 95 % CI: 1.09–3.73), 6–10 years (AOR: 2.81; 95 % CI: 1.55–5.11), ≥11 years (AOR: 3.35; 95 % CI: 1.84–6.11); prior HIV testing (AOR: 1.60; 95 % CI: 1.35–1.91), self-reported risky-injection behavior (AOR: 1.60; 95 % CI: 1.33–1.92), and utilization of harm-reduction services (AOR: 1.32; 95 % CI: 1.11–1.58) were positively associated with HIV infection. Alcohol use ≤2 times/week (AOR: 0.67; 95 % CI: 0.55–0.82) or ≥3 times/week (AOR: 0.74; 95 % CI: 0.54–1.01), unit increase in age (AOR: 0.99; 95 % CI: 0.98–1.00), ≥7 years of schooling (AOR: 0.82; 95 % CI: 0.66–1.02) and unsafe sex with any female partner (AOR: 0.69; 95 % CI: 0.55–0.86) were negatively associated with HIV infection. HIV prevalence remains high among male IDUs in Delhi. HIV prevention programs should include comprehensive package of services for IDUs.

Keywords

Injection drug user HIV Harm reduction Sexual behavior Unsafe injection practices 

References

  1. 1.
    NACO. Annual Report. Department of AIDS Control, Ministry of Health and Family Welfare, 2009–2010.Google Scholar
  2. 2.
    NACO. National AIDS Control Programme Phase III: State Fact Sheets. Report No. http://www.nacoonline.org/upload/IEC%20Division/Parliamentarian%20Forum%204-5%20july%202011/NACO%20Fact%20Sheet.pdf (2011). Accessed 8 Sept 2012.
  3. 3.
    Sarna A, Tun W, Bhattacharya A, Lewis D, Singh Y, Apicella L. Assessment of unsafe injection practices and sexual risk behaviors among male injecting drug users in two urban cities of India using respondent driven sampling. Southeast Asian J Trop Med Hyg. 2012;43(3):652–67.Google Scholar
  4. 4.
    Mahanta J, Medhi G, Paranjpe R, Roy N, Kohli A, Akojiam B, et al. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS. 2008;22(Supplement 5):S59–68.PubMedCrossRefGoogle Scholar
  5. 5.
    Panda S, Kumar M, Lokabiraman S, Jayashree K, Satagopan M, Solomon S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr. 2005;39(1):9–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Panda S, Chatterjee A, Bhattacharya SK, Manna B, Singh PN, Sarkar S, et al. Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS. 2000;11:468–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Uusküla A, McMahon MJ, Kals M, Talu A, Abel-Ollo K, Rüütel K, Jarlais DC. Risk for heterosexual HIV transmission among non-injecting female partners of injection drug users in Estonia. AIDS Behav. 2011. doi:10.1007/s10461-011-0078-9.
  8. 8.
    Latkin C, Srikrishnan A, Yang C, Johnson S, Solomon S, Kumar S, et al. The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug Alcohol Depend. 2010;110(3):221–7.PubMedCrossRefGoogle Scholar
  9. 9.
    NACO. National Behaviour Surveillance Survey. Delhi: National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 2006.Google Scholar
  10. 10.
    Solomon S, Srikrishnan A, Celentano D, Johnson S, Vasudevan C, Murugavel K, et al. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India. BMC Public Health. 2011;11(39):10.Google Scholar
  11. 11.
    Des Jarlais DC, Perlis T, Poznyak V. Characteristics of injecting drug users (IDUs) in different regions of the world: WHO Phase II Study. Paper presented at the international conference on the reduction of drug related harm, Melbourne;2004.Google Scholar
  12. 12.
    Des Jarlais DC, Semaan S. Interventions to reduce the sexual risk behaviour of injecting drug users. Int J Drug Policy. 2005;16S:S58–66.CrossRefGoogle Scholar
  13. 13.
    Desenclos JC, Papaevangelou G, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. AIDS. 1993;7(10):1371–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Vanichseni S, Choopanya K, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, et al. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 1992;5(11):1119–23.PubMedGoogle Scholar
  15. 15.
    Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, Heimer R. HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav. 2011;15(1):45–7.PubMedCrossRefGoogle Scholar
  16. 16.
    NACO. HIV sentinel surveillance and HIV estimation in India 2007. A technical brief. http://www.nacoonline.org/upload/Publication/M&E%20Surveillance,%20Research/HIV%20Sentinel%20Surveillance%20and%20HIV%20Estimation%202007_A%20Technical%20Brief (2007). Accessed 8 Sept 2012.
  17. 17.
    Baveja B, Chattopadhya D, Khera R, Joshi P. A cross sectional serological study of the co-infection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. Indian J Med Microbiol. 2003;21(4):280–3.PubMedGoogle Scholar
  18. 18.
    Solomon SS, Celentano DD, Srikrishnan AK, Vasudevan CK, Murugavel KG, Iqbal SH, Anand S, Kumar MS, Latkin C, Solomon S, Mehta SH. Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India. Am J Epidemiol. 2010;172(11):1259–67.PubMedCrossRefGoogle Scholar
  19. 19.
    Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, Anand S, Kumar MS, Latkin C, Solomon S, Celentano DD. High prevalence of HIV, HIV/hepatitis C virus co-infection and risk behaviors among IDUs in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr. 2008;49(3):327–32.PubMedCrossRefGoogle Scholar
  20. 20.
    NACO. Operational guidelines for integrated counseling and testing centres. http://nacoonline.org/upload/Policies%20&%20Guidelines/20,%20Operational%20Guidelines%20for%20Integrated%20Counseling%20and%20Testing%20Centres (2007). Accessed 15 Sept 2012.
  21. 21.
    Behrens T, Taeger D, Wellmann J, Keil U. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratios and prevalence ratio. Methods Inf Med. 2004;43(5):505–9.PubMedGoogle Scholar
  22. 22.
    Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Cook T. Advanced statistics: up with odds ratios! A case for odds ratios when outcomes are common. Acad Emerg Med. 2002;9:1430–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Eicher A, Crofts N, Benjamin S, Deutschmann P, Rodger A. A certain fate: spread of HIV among young injecting drug users in Manipur, North-East India. AIDS CARE. 2000;12(4):497–504.PubMedCrossRefGoogle Scholar
  25. 25.
    Buxton M, Vlahov D, Strathdee S, Jarlais DD, Morse E, Ouellet L, et al. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004;75(2):177–83.CrossRefGoogle Scholar
  26. 26.
    Fennema J, Ameijden EV, Hoek AVD, Coutinho R. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997;92:1457–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, Beyrer C, et al. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J Acquir Immune Defic Syndr. 2003;33(2):259–66.PubMedCrossRefGoogle Scholar
  28. 28.
    Vanichseni S, Kityaporn T, Maestro T. Continued high HIV-1 incidence in a vaccine preparatory trial cohort of injection drug users in Bangkok, Thailand. AIDS. 2001;15:397–405.PubMedCrossRefGoogle Scholar
  29. 29.
    Corneil T, Kuyper L, Shoveller J, Hogg R, Li K, Spittal P, et al. Unstable housing, associated risk behaviour and increased risk for HIV infection among injection drug users. Health Place. 2006;12:78–85.CrossRefGoogle Scholar
  30. 30.
    Jarlais DD, Braine N, Friedmann P. Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs. AIDS Behav. 2007;1(6 Supplement):78–94.CrossRefGoogle Scholar
  31. 31.
    Oetting ER, Beauvais F. Peer cluster theory: drugs and the adolescent. J Couns Dev. 1986;65(1):17–22.CrossRefGoogle Scholar
  32. 32.
    Wattana W, van Griensven F, Rhucharoenpornpanich O, et al. Respondent driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alcohol Depend. 2007;90:228–33.PubMedCrossRefGoogle Scholar
  33. 33.
    NACO. Targeted interventions under NACP III, Volume I: core high risk groups. http://www.nacoonline.org/upload/Publication/NGOs%20and%20targetted%20Intervations/NACP-III.pdf (2007). Accessed 10 Oct 2012.
  34. 34.
    Samuels J, Vlahov D, Anthony J, Chaisson R. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992;87(3):417–28.PubMedCrossRefGoogle Scholar
  35. 35.
    Block J, Block JH, Keyes S. Longitudinally foretelling drug usage in adolescence: early childhood personality and environmental precursors. Child Dev. 1988;59(2):336–55.PubMedCrossRefGoogle Scholar
  36. 36.
    Salganik M, Heckathorn D. Sampling and estimation in hidden populations using respondent-driven sampling. Soc Methodol. 2004;34:193–239.CrossRefGoogle Scholar
  37. 37.
    Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden population for HIV surveillance. AIDS. 2005;19(Supplement 2):S67–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Avina Sarna
    • 1
  • Waimar Tun
    • 2
  • Vartika Sharma
    • 3
  • Mary Sebastian
    • 3
  • Ira Madan
    • 4
  • Amita Yadav
    • 3
  • Meredith Sheehy
    • 5
  • Dean Lewis
    • 4
  • Ibou Thior
    • 6
  1. 1.Population CouncilNew DelhiIndia
  2. 2.Population CouncilWashingtonUSA
  3. 3.Population CouncilNew DelhiIndia
  4. 4.Sahara Centre for Residential Care and RehabilitationNew DelhiIndia
  5. 5.One Dag Hammarskjold PlazaNew YorkUSA
  6. 6.ARISE Project, PATHWashingtonUSA

Personalised recommendations